Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.45 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 4/20 | 0.45 |
| ▸ | CNR2 | P34972 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.45 |
| ▸ | PTGES | O14684 | 2/20 | 0.43 |
| ▸ | TOP2A | P11388 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19677652 | 0.90 | NR1H2 (0.49) | NR1H2NR1H3KDM4EPTPN1CA12 | |
| SCHEMBL11316813 | 0.84 | PTGES (0.55) | NR1H2NR1H3KDM4ENOD2PTGES | |
| SCHEMBL5676264 | 0.81 | NR1H2 (0.47) | NR1H2NR1H3KDM4ENOD2PTGES | |
| SCHEMBL19680128 | 0.81 | NR1H2 (0.51) | NR1H2NR1H3KDM4ENOD2PTGES | |
| SCHEMBL9396779 | 0.80 | PTPN1 (0.53) | NR1H2NR1H3KDM4ENOD2PTGES | |
| SCHEMBL8750720 | 0.79 | PTGES (0.66) | NR1H2NR1H3KDM4ENOD2PTGES | |
| SCHEMBL29979434 | 0.79 | PTGES (0.66) | NR1H2NR1H3KDM4ENOD2PTGES | |
| SCHEMBL31643701 | 0.78 | CYP3A4 (0.63) | NR1H2NR1H3KDM4ECA12CA1 | |
| SCHEMBL8400549 | 0.78 | PTPN1 (0.66) | NR1H2NR1H3KDM4ENOD2PTGES | |
| SCHEMBL8402307 | 0.78 | PTPN1 (0.66) | NR1H2NR1H3KDM4ENOD2PTGES |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170349518-A1 | Crystalline Form of Cannabidiol | S&B PHARMA, INC., DBA NORAC PHARMA | 2017-12-07 | — | — | US | disclosed |
| US-20170349518-A1 | Crystalline Form of Cannabidiol | S&B PHARMA, INC., DBA NORAC PHARMA | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170349518-A1 | Crystalline Form of Cannabidiol | CNR1, CNR2, CALCOCO2 | NR1H2 35/4885NR1H3 36/4885CNR1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.